Obesity and dyslipidemia

Endocrinology and Metabolism Clinics of North America

Volumn 32, Issue 4, 2003, Pages 855-867

  Howard, Barbara V ^a   Ruotolo, Giacomo ^b   Robbins, David C ^c  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; BODY FAT; BODY MASS; BODY WEIGHT; DYSLIPIDEMIA; ETHNIC GROUP; EXERCISE; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; WEIGHT REDUCTION;

EID: 0347363630     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(03)00073-2     Document Type: Review

References (35)

1. National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998;6(Suppl 2);464.
2. Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to high blood cholesterol levels in white American men. Arch Intern Med 1993;153:1093-103.
3. Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med 1994;154:401-10.
4. Sternfeld B, Sidney S, Jacobs DR Jr, Sadler MC, Haskell WL, Schreiner PJ. Seven-year changes in physical fitness, physical activity, and lipid profile in the CARDIA study. Coronary artery risk development in young adults. Ann Epidemiol 1999;9(1):25-33.
5. Jalkanen L. The effect of a weight reduction program on cardiovascular risk factors among overweight hypertensives in primary health care. Scand J Soc Med 1991;19:66-71.
6. Folsom AR, Burke GL, Ballew C, Jacobs DR Jr, Haskell WL, Donahue RP, et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites: the roles of insulin. Am J Epidemiol 1989;130:911-24.
7. Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK. Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes 1987;36:43-51.
8. Howard BV, Bogardus C, Ravussin E, Foley JE, Lillioja S, Mott DM, et al. Studies of the etiology of obesity in Pima Indians. Am J Clin Nutr 1991;53:1577S-85S.
9. Anderson KM, Wilson PW, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis 1987;68:59-66.
10. Marniemi J, Seppanen A, Hakala P. Long-term effects on lipid metabolism of weight reduction on lactovegetarian and mixed diet. Int J Obes Relat Metab Disord 1990;14:113-25.
11. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991;325:461-6.
12. Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988;319:1173-9.
13. Karvetti RL, Hakala P. A 7-year follow-up of a weight reduction programme in Finnish primary health care. Eur J Clin Nutr 1992;46:743-52.
14. Burke GL, Bild DE, Hillner JE, Folsom AR, Wagenknecht LE, Sidney S. Differences in weight gain in relation to race. gender, age and education in young adults: The CARDIA study. Coronary Artery Risk Development in Young Adults. Ethn Health 1996;1:327-35.
15. Howard BV, Davis MP, Pettitt DJ, Knowler WC, Bennett PH. Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians. Circulation 1983;68:714-24.
16. Shekelle RB, Shryock AM, Paul O, Lepper M, Stamler J, Liu S, et al. Diet, serum cholesterol, and death from coronary heart disease: the Western Electric Study. N Engl J Med 1981;304:65-70.
17. Williams PT, Krauss RM. Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. Arterioscler Thromb Vasc Biol 1997;17:1082-90.
18. Gray GS, et al. Int J Obes Relat Metab Disord 2000;24(7):849-60.
19. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
20. Seidell JC, Cigolini M, Deslypere JP, Charzewska J, Ellsinger BM, Cruz A. Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men: the European Fat Distribution Study. Atherosclerosis 1991;86:251-60.
21. Dowling HJ, Pi-Sunyer X. Race-dependent health risks of upper body obesity. Diabetes 1993;42:537-43.
22. Hu D, Hannah J, Gray RS, Jablonski KA, Henderson JA, Robbins DC, et al. Effects of obesity and body fat distribution on lipids and lipoproteins in nondiabetic American Indians: the Strong Heart Study. Obes Res 2000;8(6):411-21.
23. nd edition. West Sussex, UK: John Wiley & Sons; 1995. p. 531-9.
24. National Institutes of Health. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Washington, DC: US Government Printing Office; 2001. Publication #NIH 01-3670.
25. Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta 1994;1215:9-32.
26. Egusa G, Beltz WF, Grundy SM, Howard BV. The influence of obesity on the metabolism of apolipoprotein B in man. J Clin Invest 1985;76:596-603.
27. Kesaniemi YA, Beltz WF, Grundy SM. Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest 1985;76:586-95.
28. Howard BV. Obesity, cholelithiasis, and lipoprotein metabolism in man. In: Grundy SM editor. Bile acids and atherosclerosis. Vol. 15. New York: Raven Press; 1986. p. 169-86.
29. Kendrick JS, Wilkinson J, Cartwright IJ, Lawrence S, Higgins JA. Regulation of the assembly and secretion of very low density lipoproteins by the liver. Biol Chem 1998;379:1033-40.
30. Miyashita Y, Shirai K, Itoh Y, Sasaki H, Totsuka M, Murano T, et al. Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy. Diabetes Res Clin Pract 2002;56(3):181-7.
31. Taskinen MR. Lipoprotein lipase in diabetes. Diabetes Metab Rev 1987;3:551-70.
32. Streicher R, Kotzka J, Muller-Wieland D, Siemeister G, Munck M, Avci H, et al. SREBP-I mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem 1996;271:7128-33.
33. Kwiterovich PO Jr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol 2002;90:30i-47i.
34. Lund-Katz S, Laplaud PM, Phillips MC, Chapman MJ. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction. Biochemistry 1998;37:12867-74.
35. Frenais R, Nazih H, Ouguerram K, Maugeais C, Zair Y, Bard JM, et al. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus. J Clin Endocrinol Metab 2001;86:1962-7.